Position in ZNTL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$294,294
+$39,709 QoQ
Shares Held
125,767
-33.3% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. ZNTL ranks #197 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in ZNTL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $294,294 | 125,767 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $254,585 | 188,582 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $262,167 | 173,621 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $180,628 | 155,714 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $237,678 | 149,484 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $154,140 | 50,872 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $189,379 | 51,462 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $220,078 | 53,809 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $856,807 | 54,366 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $377,991 | 24,950 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,739,412 | 136,561 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,675,198 | 130,280 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $440,886 | 25,633 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $504,666 | 25,058 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $585,165 | 27,016 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $663,860 | 23,625 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,496,572 | 97,455 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,418,805 | 219,115 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,717,309 | 130,812 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,727,245 | 145,249 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $10,110,172 | 233,007 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,339,023 | 276,069 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,927,932 | 273,109 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,320,411 | 277,393 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||